<i>MELK</i> has recently attracted considerable interest in cancer biology due to its aberrant overexpression in various malignancies, including glioma, breast, lung, colorectal, gastric, and hematological cancers. This evidence concerns the gene MELK and hematopoietic and lymphoid cell neoplasm.